Weekly Recap | CLOVER BIO-B +17.25%, outperforming the HSI by ~20ptsWeekly Review·Nov 14, 2026 at 05:16 AM02197-1.21%
Clover Biopharmaceuticals climbs 13% in Hong Kong tradingMarket Movers·Nov 10, 2026 at 01:45 AM02197-1.21%
Clover Biopharmaceuticals surges 12% in Hong Kong tradingMarket Movers·Nov 9, 2026 at 01:55 AM02197-1.21%
Weekly Recap | CLOVER BIO-B +5.88%, consensus target above spotWeekly Review·Nov 7, 2026 at 09:35 AM02197-1.21%
Clover Biopharmaceuticals climbs 7% in Hong Kong tradingMarket Movers·Oct 28, 2026 at 01:32 AM02197-1.21%
Clover Biopharmaceuticals climbs 6% in Hong Kong tradingMarket Movers·Oct 26, 2026 at 02:25 AM02197-1.21%
Weekly Recap | CLOVER BIO-B -24.03%, sliding 16% in a dayWeekly Review·Oct 24, 2026 at 05:18 AM02197-1.21%
Hong Kong's forgotten small caps ride insurance stakes, FDA wins and buybacksGlobal Report·Oct 20, 2026 at 10:50 AM013410.00%81810+0.08%
Good Earnings, Falling Prices: Hong Kong's New Listings Get Their First Real TestGlobal Report·Oct 13, 2026 at 10:51 AM02589+0.47%06658+0.55%
Hong Kong Small-Caps Navigate Growth Crossroads: Biotech Deals and Crypto Bets Take Center StageGlobal Report·Oct 13, 2026 at 09:24 AM02617-0.14%00434-0.22%
Weekly Recap | CLOVER BIO-B -2.99%, consensus target sits above spotWeekly Review·Oct 10, 2026 at 05:19 AM02197-1.21%
Hong Kong's Small Caps Are Refinancing Two Ways: Shares and MoleculesGlobal Report·Oct 6, 2026 at 10:49 AM02685-1.36%09985+1.59%